1,721,209 research outputs found
Sette lingue e un albo illustrato : un progetto interculturale per la valorizzazione delle lingue madri nella scuola dell'infanzia
Full text linkL’articolo presenta un progetto interculturale che ha avuto il principale obiettivo di valorizzare la lingua madre di ogni bambino, a partire dalla let- tura di alcuni albi illustrati. Il percorso ha preso avvio da un’indagine sulle lingue parlate in famiglia che sono state proposte a scuola grazie al coinvol- gimento di alcuni genitori. In particolare, le lingue “straniere” sono diven- tate un’occasione per conoscere altre parole, per ascoltare suoni sconosciuti che sono stati messi a confronto con altrettante parole della lingua italiana, scoprendo così differenze e somiglianze
Going Beyond Counting First Authors in Author Co-citation Analysis
Full text linkThe present study examines one of the fundamental aspects of author co-citation analysis (ACA) - the way co-citation
counts are defined. Co-citation counting provides the data on which all subsequent statistical analyses and mappings
are based, and we compare ACA results based on two different types of co-citation counting - the traditional type that
only counts the first one among a cited work's authors on the one hand and a non-traditional type that takes into
account the first 5 authors of a cited work on the other hand. Results indicate that the picture produced through this non-traditional author co-citation counting contains more coherent author groups and is therefore considerably clearer. However, this picture represents fewer specialties in the research field being studied than that produced through the traditional first-author co-citation counting when the same number of top-ranked authors is selected and analyzed. Reasons for these effects are discussed
Porotic hyperostosis as a marker of health and nutritional conditions during childhood: Studies at the transition between imperial Rome and the early middle ages
No full textPorotic hyperostosis, characterized by small and localized perforations on the surface of cranial bones, is considered a good indicator for assessing the health and nutritional status of past human populations. The most widely accepted theory at present indicates that anemias, either acquired or of genetic origin, are responsible for the bony lesions described as porotic hyperostosis. In this paper, the prevalence of these lesions in two skeletal samples from Latium (central Italy) was used to evaluate health and life conditions in Italy after the collapse of the Roman Empire. One sample belongs to the Roman Imperial Age (1st-3rd centuries A.D.) rural town of Lucus Feroniae; the other comes from the 7th century A.D. Lombard necropolis of Selvicciola. The prevalence of cribra orbitalia and cribra cranii was quite similar in the two samples but slightly more frequent in the Medieval community. Differential diagnosis suggested iron deficiency anemia in early childhood as the causative agent of the hyperostotic lesions in both samples. These results may be interpreted in light of previous examinations of same samples and according to their respective historical and socio-economical characteristics. (C) 2001 Wiley-Liss, Inc
sj-pptx-3-tam-10.1177_17588359221095064 – Supplemental material for Onvansertib and paclitaxel combined in platinum-resistant ovarian carcinomas
No full textSupplemental material, sj-pptx-3-tam-10.1177_17588359221095064 for Onvansertib and paclitaxel combined in platinum-resistant ovarian carcinomas by Roberta Affatato, Michela Chiappa, Federica Guffanti, Francesca Ricci, Laura Formenti, Robert Fruscio, Marta Jaconi, Maya Ridinger, Mark Erlander and Giovanna Damia in Therapeutic Advances in Medical Oncology</p
sj-docx-1-tam-10.1177_17588359221095064 – Supplemental material for Onvansertib and paclitaxel combined in platinum-resistant ovarian carcinomas
No full textSupplemental material, sj-docx-1-tam-10.1177_17588359221095064 for Onvansertib and paclitaxel combined in platinum-resistant ovarian carcinomas by Roberta Affatato, Michela Chiappa, Federica Guffanti, Francesca Ricci, Laura Formenti, Robert Fruscio, Marta Jaconi, Maya Ridinger, Mark Erlander and Giovanna Damia in Therapeutic Advances in Medical Oncology</p
sj-pptx-5-tam-10.1177_17588359221095064 – Supplemental material for Onvansertib and paclitaxel combined in platinum-resistant ovarian carcinomas
No full textSupplemental material, sj-pptx-5-tam-10.1177_17588359221095064 for Onvansertib and paclitaxel combined in platinum-resistant ovarian carcinomas by Roberta Affatato, Michela Chiappa, Federica Guffanti, Francesca Ricci, Laura Formenti, Robert Fruscio, Marta Jaconi, Maya Ridinger, Mark Erlander and Giovanna Damia in Therapeutic Advances in Medical Oncology</p
Suppl_Table_2 – Supplemental material for Overcoming platinum-acquired resistance in ovarian cancer patient-derived xenografts
No full textSupplemental material, Suppl_Table_2 for Overcoming platinum-acquired resistance in ovarian cancer patient-derived xenografts by Francesca Ricci, Laura Brunelli, Roberta Affatato, Rosaria Chilà, Martina Verza, Stefano Indraccolo, Francesca Falcetta, Maddalena Fratelli, Robert Fruscio, Roberta Pastorelli and Giovanna Damia in Therapeutic Advances in Medical Oncology</p
Suppl_Fig_2 – Supplemental material for Overcoming platinum-acquired resistance in ovarian cancer patient-derived xenografts
No full textSupplemental material, Suppl_Fig_2 for Overcoming platinum-acquired resistance in ovarian cancer patient-derived xenografts by Francesca Ricci, Laura Brunelli, Roberta Affatato, Rosaria Chilà, Martina Verza, Stefano Indraccolo, Francesca Falcetta, Maddalena Fratelli, Robert Fruscio, Roberta Pastorelli and Giovanna Damia in Therapeutic Advances in Medical Oncology</p
sj-pptx-1-tam-10.1177_17588359221095064 – Supplemental material for Onvansertib and paclitaxel combined in platinum-resistant ovarian carcinomas
No full textSupplemental material, sj-pptx-1-tam-10.1177_17588359221095064 for Onvansertib and paclitaxel combined in platinum-resistant ovarian carcinomas by Roberta Affatato, Michela Chiappa, Federica Guffanti, Francesca Ricci, Laura Formenti, Robert Fruscio, Marta Jaconi, Maya Ridinger, Mark Erlander and Giovanna Damia in Therapeutic Advances in Medical Oncology</p
- …
